Respiratory syncytial virus-specific IgE antibody responses at the mucosal surface: predictive value for recurrent wheezing and suppression by ribavirin therapy.
Welliver
R C
RC
Department of Pediatrics, State University of New York at Buffalo.
Ogra
P L
PL
D000914:Antibodies, Viral / Q000096:biosynthesis*; D001990:Bronchiolitis, Viral / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000096:biosynthesis; D007073:Immunoglobulin E / Q000096:biosynthesis; D007223:Infant; D008297:Male; D012135:Respiratory Sounds / Q000209:etiology; D012136:Respiratory Syncytial Viruses / Q000276:immunology; D010253:Respirovirus Infections / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D012254:Ribavirin / Q000627:therapeutic use
D000914:Antibodies, Viral; D007070:Immunoglobulin A; D007073:Immunoglobulin E; D012254:Ribavirin